Medtronic PLC (MDT) FY2026Q3 Earning Prediction
Medtronic PLC (MDT) is set to release its FY2026Q3 earnings performance on 02/17 06:45:00 ET in Pre-Market trading. Consensus forecasts predict a revenue of 8.90B and an earnings per share (EPS) of 1.33 for the FY2026Q3. With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
AI Earnings Prediction
The earnings forecast predicts a beat due to strong product launches, margin improvements, and operational leverage.
Scenario Analysis
Key Indicators Forecast
No data
Prediction Logic & Rational
Logic & Justification
Fact Data Highlights:
- Cardiovascular Growth Catalysts:
Acquisition of CathWorks ($585M) expands coronary disease diagnostic capabilities, enhancing CAS portfolio.
Affera ablation system ramping in U.S. and international markets (Wells Fargo projects $1B incremental CAS sales by 2027).
Hugo robotic surgery system FDA-cleared for urologic procedures, expanding surgical robotics revenue streams.
- Diabetes U.S. Demand Surge:
MiniMed 780G system launched with Medicare coverage and FDA clearance for ultra-rapid insulins and insulin-requiring type 2 diabetes.
Over 35,000 backlogged U.S. sensor orders (per prior quarter) likely fulfilled with new product availability.
- Neuroscience Innovations:
- Partnership with Precision Neuroscience integrates brain-computer interface tech into Medtronic’s StealthStation, potentially accelerating adoption of Specialty Therapies.
- Margin Improvements:
- Cost efficiency programs and premium pricing for new products (e.g., MiniMed 780G, Hugo) support gross margin expansion. Needham cited "profitability improvements" as a key driver.
- EPS Upside:
- Operational leverage from revenue growth and tax expense reductions (prior EPS beat by $ 0.05) likely to persist.
Tactical Strategy Recommendations
Trading Strategy
Equities:
- Long MDT ahead of earnings: Fact data supports bullish thesis on product cycle momentum.
- Pair Trade: Long MDT / Short peers with weaker pipelines (e.g., Boston Scientific).
Options: - Bull Call Spread: Buy $105 calls / Sell $115 calls expiring March 2026.
- Hedge: Buy protective puts at $95 (low probability of Strong Miss).
Catalysts to Monitor: - Early MiniMed 780G shipment data (pre-earnings channel checks).
- Hugo robotic system adoption rates in urology.
- CathWorks FTC clearance progress.
Earnings Surprise Analysis
MDT Transcript
Medtronic's earnings call reveals strong revenue growth, positive product developments, and optimistic guidance. The increase in full-year revenue growth guidance to 5.5% and the raised EPS guidance reflect confidence in future performance. The Q&A section supports this with plans for accelerated growth in key areas and high single-digit EPS growth. Despite some management vagueness, the overall sentiment is positive, with strong growth in the MedSurg and Diabetes businesses and strategic investments. The lack of market cap information limits the prediction accuracy, but the strong fundamentals suggest a positive stock price movement.
The earnings call summary reveals positive financial performance with growth in key segments and improved margins. Despite some declines, overall growth in revenue and EPS exceeded expectations. The Q&A section highlights management's confidence in product launches and strategic investments, though some details were vague. The raised guidance and strong pipeline, particularly in cardiovascular and neuroscience, indicate positive sentiment. The combination of these factors suggests a positive stock price movement over the next two weeks.
MDT Report
Frequently Asked Questions
What is the Medtronic PLC FY2026Q3 Earnings Release Date and Time?
Medtronic PLC (MDT) is scheduled to release its FY2026Q3 earnings report on Feb 17, 2026, Pre-Market (approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Medtronic PLC FY2026Q3 Revenue and EPS?
Analysts' consensus predicts 8.90B in revenue and an EPS of 1.33 for Medtronic PLC's FY2026Q3.
What Does Intellectia's AI Predict for Medtronic PLC FY2026Q3 Earnings?
Intellectia's exclusive AI algorithms forecast a Beat for Medtronic PLC's FY2026Q3 earnings, with a prediction date of Feb 17, 2026. Medtronic PLC The earnings forecast predicts a beat due to strong product launches, margin improvements, and operational leverage.
How Can I Use This Earnings Prediction to Trade MDT Stock?
Leverage Intellectia's AI forecast to position trades ahead of the Feb 17, 2026 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Medtronic PLC FY2026Q3?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company's earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They're updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
